Explore the words cloud of the GNU200 project. It provides you a very rough idea of what is the project "GNU200" about.
The following table provides information about the project.
GNUBIOTICS SCIENCES SARL
|Coordinator Country||Switzerland [CH]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3.2.4. (Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy)
2. H2020-EU.3.2.1. (Sustainable agriculture and forestry)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.2.2. (Sustainable and competitive agri-food sector for a safe and healthy diet)
|Duration (year-month-day)||from 2018-01-01 to 2018-04-30|
Take a look of project's partnership.
|1||GNUBIOTICS SCIENCES SARL||CH (EPALINGES)||coordinator||50˙000.00|
Despite declining birth rates and the increasing number of campaigns to promote and support breastfeeding, the market for infant milk substitutes is growing. This is explained by the increasing employed female population, as well as inconvenience to breastfeed out of home. Scientific evidence indicates that breastfeeding protects against child infections and malocclusion, increases intelligence, and reduces overweight and diabetes’ probability. As an alternative to breastfeeding, parents choose to feed their babies with infant milk formulae that cannot replicate the effects and benefits of breast milk because fundamental components such as prebiotic human milk oligosaccharides (HMOs) are not included. To compensate for this lack of HMOs, oligosaccharides such as GOS and FOS are included, even though they are poor mimics of HMOs with minimal evidence of efficacy. HMOs, the third most abundant component in breast milk, are molecules naturally tailored to the need of an infant which serve as prebiotics that help shape microbiota composition, protect infants from diseases, foster healthy gastrointestinal systems, reinforce fledgling immune function, and promote early brain development. Adding HMOs in formulae will substantially improve child benefits, mimicking breast milk composition (bringing formulae closer to nature).
We, GNUbiotics, are a start-up that has developed GNU 200 thought a process based on a by-product from the meat industry. This natural prebiotic composed of a mix with high diversity and concentration of oligosaccharides with proven efficacy. Our product protects against infections, restores the microbiota diversity after antibiotics treatment and prevents the onset of diet induced obesity similarly to HMOs found in breast milk. Hence, it represents a great business opportunity several steps ahead than alternatives.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GNU200" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "GNU200" are provided by the European Opendata Portal: CORDIS opendata.